Laboratorio Elea Phoenix S.A.
Laboratorio Elea Phoenix S.A.
Explore linked clinical trials.2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms | Chemically-Induced Disorders, Parkinson disease, basal ganglia disorder, brain disorder, cannabis dependence, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, substance-related disorder, synucleinopathy | Recruiting | Phase 2 | 2024-12-05 | NCT06629389 | |
| Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease | Chagas disease, Euglenozoa Infections, Infections, parasitic infectious disease, protozoa infectious disease, trypanosomiasis, vector-borne disease | Recruiting | Phase 3 | 2023-11-30 | NCT04897516 |